2021 Á¦ 24Â÷ ´ëÇÑÇ÷¾×ÇÐȸ AML/MDS ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2021-12-18±³À°ÀÏÀÚ : 2021-12-18
±³À°Àå¼Ò : ¿¬¼¼´ëÇб³ ½ÅÃÌÄ·ÆÛ½º ¹é¾ç´©¸® ±×·£µåº¼·ëȦ
±³À°ÁÖÁ¦ :
2021 Á¦ 24Â÷ ´ëÇÑÇ÷¾×ÇÐȸ AML/MDS ¿¬±¸È¸ ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : AML/MDS¿¬±¸È¸
´ã´çÀÚ : Á¤¼¼¿µ
¿¬¶ôó : 02-533-1408
À̸ÞÀÏ :
ksh.amlmds.wp@gmail.com ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 80¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-18 ±×·£µåº¼·ë 10:00~10:40 Integrative network analysis using multi-omics data in AML À¯½Â¿(Sema4 Genomics Inc)
±³À°½Ã°£ 12-18 ±×·£µåº¼·ë 10:40~11:20 How to interpret coexisting genetic abnormalities with conflicting prognosis in AML ¾ÈÀç¼÷(Àü³²ÀÇ´ë)
±³À°½Ã°£ 12-18 ±×·£µåº¼·ë 11:20~12:00 Big data driven research in hematology Ȳ»ó¹Ì(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-18 ±×·£µåº¼·ë 13:00~13:40 Updates of pediatric AML/MDS treatment ÃÖÁ¤À±(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-18 ±×·£µåº¼·ë 13:40~14:20 Transplant for elderly AML/MDS over 65 years ÀåÁöÀº(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12-18 ±×·£µåº¼·ë 14:20~15:00 Optimal salvage therapy in AML ¹Ú½Çºñ¾Æ(°¡Å縯ÀÇ´ë)